Mo Ghafouri

703 total citations
14 papers, 528 citations indexed

About

Mo Ghafouri is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Endocrinology. According to data from OpenAlex, Mo Ghafouri has authored 14 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 3 papers in Endocrinology. Recurrent topics in Mo Ghafouri's work include Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Inhalation and Respiratory Drug Delivery (5 papers) and Asthma and respiratory diseases (5 papers). Mo Ghafouri is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Inhalation and Respiratory Drug Delivery (5 papers) and Asthma and respiratory diseases (5 papers). Mo Ghafouri collaborates with scholars based in United States, France and Germany. Mo Ghafouri's co-authors include Stephen I. Rennard, Richard Robbins, Austin B. Thompson, Mitchell Friedman, Charles W. Serby, William P. Vaughan, Ronald F. Ertl, Stephen I. Rennard, Kurt D. Christensen and Marlin G. Stahl and has published in prestigious journals such as CHEST Journal, American Journal of Clinical Pathology and Respiratory Medicine.

In The Last Decade

Mo Ghafouri

14 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mo Ghafouri United States	11	438	222	57	49	34	14	528
E. P. Munch Denmark	16	334 0.8×	361 1.6×	34 0.6×	21 0.4×	26 0.8×	26	720
J. Torres-Borrego Spain	15	199 0.5×	188 0.8×	67 1.2×	27 0.6×	76 2.2×	37	424
Jacques E. Marcotte Canada	10	387 0.9×	171 0.8×	153 2.7×	46 0.9×	60 1.8×	18	538
Gwendolyn S. Kerby United States	12	383 0.9×	74 0.3×	69 1.2×	25 0.5×	78 2.3×	20	439
Gualtiero Leo Italy	13	179 0.4×	184 0.8×	65 1.1×	20 0.4×	131 3.9×	27	527
Jamal Akhtar India	10	147 0.3×	83 0.4×	41 0.7×	14 0.3×	70 2.1×	42	336
Lea Bentur Israel	13	200 0.5×	86 0.4×	54 0.9×	7 0.1×	86 2.5×	39	383
Peter J. Jederlinic United States	10	482 1.1×	113 0.5×	73 1.3×	25 0.5×	150 4.4×	14	574
John T. Kaemmerlen United States	8	270 0.6×	196 0.9×	23 0.4×	19 0.4×	19 0.6×	12	337
Teyfik Turgut Türkiye	11	142 0.3×	112 0.5×	82 1.4×	16 0.3×	73 2.1×	25	360

Countries citing papers authored by Mo Ghafouri

Since Specialization

Citations

This map shows the geographic impact of Mo Ghafouri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo Ghafouri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo Ghafouri more than expected).

Fields of papers citing papers by Mo Ghafouri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mo Ghafouri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo Ghafouri. The network helps show where Mo Ghafouri may publish in the future.

Co-authorship network of co-authors of Mo Ghafouri

This figure shows the co-authorship network connecting the top 25 collaborators of Mo Ghafouri. A scholar is included among the top collaborators of Mo Ghafouri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mo Ghafouri. Mo Ghafouri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Donohue, James F., Robert A. Wise, William W. Busse, et al.. (2016). Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial. BMC Pulmonary Medicine. 16(1). 65–65. 14 indexed citations

ZuWallack, Richard, et al.. (2016). Efficiency of Ipratropium Bromide and Albuterol Deposition in the Lung Delivered via a Soft Mist Inhaler or Chlorofluorocarbon Metered‐Dose Inhaler. Clinical and Translational Science. 9(2). 105–113. 2 indexed citations

Ghafouri, Mo, et al.. (2015). Impaired consciousness in febrile elderly hospitalized patients in infectious disease and neurologic. Journal of North Khorasan University of Medical Sciences. 6(4). 841–849. 2 indexed citations

Crawford, Bruce, Brigitta U. Monz, Jens M. Hohlfeld, et al.. (2008). Development and validation of a cough and sputum assessment questionnaire. Respiratory Medicine. 102(11). 1545–1555. 70 indexed citations

Brazinsky, Shari A., et al.. (2003). One-Year Evaluation of the Safety and Efficacy of Ipratropium Bromide HFA and CFC Inhalation Aerosols in Patients with Chronic Obstructive Pulmonary Disease. Clinical Drug Investigation. 23(3). 181–191. 4 indexed citations

Taylor, James R., Arthur Kotch, Kathryn Rice, et al.. (2001). Ipratropium Bromide Hydrofluoroalkane Inhalation Aerosol Is Safe and Effective in Patients With COPD. CHEST Journal. 120(4). 1253–1261. 22 indexed citations

Rennard, Stephen I., et al.. (1996). Extended Therapy With Ipratropium Is Associated With Improved Lung Function in Patients With COPD. CHEST Journal. 110(1). 62–70. 92 indexed citations

Thompson, Austin B., Richard Robbins, Joseph H. Sisson, et al.. (1993). The Bronchitis Index. CHEST Journal. 103(5). 1482–1488. 37 indexed citations

Rennard, Stephen I., Mo Ghafouri, Austin B. Thompson, et al.. (1990). Fractional Processing of Sequential Bronchoalveolar Lavage to Separate Bronchial and Alveolar Samples. American Review of Respiratory Disease. 141(1). 208–217. 168 indexed citations

10.

Thompson, Austin B., Richard Robbins, Mo Ghafouri, J Linder, & S. I. Rennard. (1989). Bronchoalveolar lavage fluid processing. Effect of membrane filtration preparation on neutrophil recovery.. PubMed. 33(4). 544–9. 11 indexed citations

11.

Linder, J, Stanley J. Radio, Richard Robbins, Mo Ghafouri, & Stephen I. Rennard. (1988). Bronchoalveolar lavage in the cytologic diagnosis of carcinoma of the lung.. PubMed. 31(6). 796–801. 35 indexed citations

12.

Rennard, Stephen I., et al.. (1988). Detection of Candida antigen in bronchoalveolar lavage fluid.. PubMed. 32(3). 347–52. 10 indexed citations

13.

Linder, James, William P. Vaughan, Jamés O. Armitage, et al.. (1987). Cytopathology of Opportunistic Infection in Bronchoalveolar Lavage. American Journal of Clinical Pathology. 88(4). 421–428. 18 indexed citations

14.

Ghafouri, Mo, Kashinath D. Patil, & Irving Kass. (1984). Sputum Changes Associated with the Use of Ipratropium Bromide. CHEST Journal. 86(3). 387–393. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact